The company said shareholders elected all 13 director nominees named in the 2024 Proxy Statement at its annual meeting of shareholders held on April 25, 2024.

1. 01

   The company said shareholders elected all 13 director nominees named in the 2024 Proxy Statement at its annual meeting of shareholders held on April 25, 2024.

2. 02

   Johnson & Johnson said shareholders cast 1,511,199,544 votes for and 159,356,373 votes against the advisory say-on-pay vote on executive compensation, and approved the appointment of PricewaterhouseCoopers LLP as its independent registered public accounting firm for fiscal 2024.

3. 03

   The company said shareholders did not approve the shareholder proposal on gender-based compensation gaps and associated risks, with 64,871,020 votes for, 1,595,866,856 votes against and 19,184,907 abstentions.

4. 04

   The company said its board adopted amended and restated by-laws on April 25, 2024, effective the same day, and updated requirements for shareholder requests to call special meetings and for director nominations, including procedures and information requirements.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.